AUDDIA INC. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by AUDDIA INC. on December 18, 2023, reporting events occurring on December 12, 2023. The company is incorporated in Delaware and trades on the Nasdaq Stock Market under the symbols AUUD (Common Stock) and AUUDW (Warrants). The filing primarily addresses the appointment of a new Chief Financial Officer and the execution of a related employment agreement.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity metrics. This report focuses exclusively on executive compensation and employment terms rather than financial performance results.
Material Changes and Executive Appointment
On December 12, 2023, the Board of Directors appointed John E. Mahoney as the new Chief Financial Officer. An Employment Agreement was entered into on December 18, 2023, effective as of November 27, 2023. Mr. Mahoney brings over twenty years of finance and operational experience, including previous roles as CFO at Quality Biomedical, Inc. and TASQ Technology, Inc.
Compensation and Equity Grants
- Base Salary: $275,000 annually, subject to adjustment.
- Annual Bonus: Eligible for up to 50% of base salary at the discretion of the Board.
- Stock Options:
- 275,000 shares vesting in four equal annual installments.
- 192,500 shares vesting 50% after two years, followed by two 25% annual installments.
- Exercise price of $0.25 per share (equal to closing price on grant date).
- 10-year term with accelerated vesting upon termination without cause or for good reason within 12 months of a change in control.
- Severance: In the event of termination without cause or resignation for good reason, the executive receives nine months of base salary, nine months of COBRA health insurance, and any earned but unpaid bonus.
Risks and Contingencies
The Employment Agreement includes standard non-competition and non-solicitation provisions effective for twelve months post-termination. The agreement also mandates confidentiality and the execution of invention assignment agreements. No other material risks or contingencies were disclosed in this specific filing.
Investor Verification Checklist
- Verify the total dilution impact of the 467,500 new stock options granted to the new CFO.
- Confirm the company's current cash position to ensure it can support the new executive's salary and potential bonus obligations.
- Review the full text of the Employment Agreement (Exhibit 10.1) for specific definitions of "good reason" and "change in control."
- Monitor future filings for the first financial report prepared under the new CFO's oversight.